Parkinson's disease (PD) is an age-related, progressive neurodegenerative disorder. The hallmark of PD pathogenesis is the Lewy bodies (LBs) that accumulate in neurons in the substantia nigra region ...
Those with the sleep condition were more likely to develop Parkinson’s disease. But one treatment was found to help. By Caroline Hopkins Legaspi In a study published Monday in JAMA Neurology, ...
In addition to offering its Syn-One Biomarker Services for use in biopharmaceutical sponsors' clinical trials, CND is continuing to study the use of the Syn-One Research Test and NerValence to ...
As Part of an Exploratory Outcome, ABLi Therapeutics Used CND's Syn-One Biomarker Services to Quantify and Visualize a Decrease in Phosphorylated Alpha-Synuclein in Cutaneous Nerves of Patients in a ...
Launched in 2019, the Syn-One Test is used by neurologists and other clinicians in all 50 states to aid in the diagnosis of synucleinopathies SCOTTSDALE, Ariz., Nov. 6, 2025 /PRNewswire/ -- CND Life ...
The MarketWatch News Department was not involved in the creation of this content. Launched in 2019, the Syn-One Test is used by neurologists and other clinicians in all 50 states to aid in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback